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Abstract
Epithelial cells in the human small intestine express
meprin, an astacin-like metalloprotease, which accumu-
lates normally at the brush border membrane and in the
gut lumen. Therefore, meprin is targeted towards luminal
components. In coeliac disease patients, peptides from
ingested cereals trigger mucosal inflammation in the
small intestine, disrupting epithelial cell differentiation
and function. Using in situ hybridisation on duodenal tis-
sue sections, we observed a marked shift of meprin
mRNA expression from epithelial cells, the predominant
expression site in normal mucosa, to lamina propria
leukocytes in coeliac disease. Meprin thereby gains
access to the substrate repertoire present beneath the
epithelium.
Keywords: endopeptidases; enteritis; enterocytes;
gluten; inflammation; leukocytes.
In coeliac disease, inflammatory reaction in the mucosa
is triggered in susceptible individuals by gliadin-derived
peptides, which activate lamina propria and intraepithelial
T-cells, thereby promoting tissue damage consisting of
villus atrophy and crypt hyperplasia (Sollid, 2002; Shan
et al., 2002, 2005; Koning, 2005). Proteases, in particular
matrix metalloproteases (MMPs), are believed to play a
These authors contributed equally to this worka
major role in these processes. Indeed, enhanced expres-
sion of MMP-1 and MMP-3 has been documented in the
intestinal mucosa of coeliac disease patients (Daum
et al., 1999). In addition, activation of lamina propria T-
cells in organ cultures of human foetal gut explants leads
to increased production of pro-inflammatory cytokines
from T-helper 1 (Th1) cells and upregulation of MMP-3
and MMP-12, which causes morphological changes that
mimic those observed in coeliac disease. Addition of
synthetic MMP inhibitors prevented deterioration of the
mucosa in this system (Pender et al., 1997; Monteleone
et al., 1999; Salmela et al., 2001). We hypothesised that
expression of meprin, an astacin-like metalloprotease
that is constitutively expressed by intestinal epithelial
cells and thus provides continuous proteolytic activity
directed towards the gut lumen (Sterchi et al., 1988b;
Dumermuth et al., 1991; Lottaz et al., 1999a), might be
altered in coeliac disease.
Meprin (EC 3.4.24.18) is distinct from MMPs in terms
of structure and multi-domain organisation (Dumermuth
et al., 1991). The protease consists of homo- and hetero-
oligomeric complexes of two homologous isoforms,
meprin a and meprin b, which accumulate at the brush
border membrane of villus enterocytes and are partially
secreted into the gut lumen. Biosynthesis of meprin has
been studied in intestinal biopsies in organ culture (Ster-
chi et al., 1988a) and in transfected mammalian cells
(Gru¨nberg et al., 1993; Eldering et al., 1997; Pischitzis
et al., 1999). Different forms were observed, generated
by posttranslational modifications and proteolytic proc-
essing along the secretory pathway. Both meprin a and
meprin b are synthesised as glycosylated transmem-
brane proteins, and smaller soluble forms are generated
through proteolytic processing steps. The 100-kDa pre-
cursor form of meprin a is retained in the endoplasmic
reticulum, where a proteolytic processing step leads to
the removal of its membrane anchor. This soluble 80–85-
kDa form, which still contains carbohydrate moieties that
are sensitive to digestion by endoglycosidase H, is sub-
sequently transported through the Golgi complex,
acquiring complex glycosylation, and is finally secreted
as the mature soluble 90–95-kDa protein. Meprin b is
transported to the cell surface as a transmembrane pro-
tein (100–105 kDa), but may also be partially shed from
the membrane as a 90–95-kDa protein. Both meprin a
and meprin b form disulfide-bonded dimers. Meprin a
may be retained at the cell surface through covalent
association with transmembrane meprin b via disulfide
bonds. Meprin a associates into multimeric protein com-
plexes via non-covalent interactions (Becker et al., 2003;
Bertenshaw et al., 2003).
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Figure 1 Meprin expression in inflamed small intestinal mucosa of untreated coeliac disease patients and in normal control mucosa.
Biopsy specimens were collected during upper endoscopy from the duodenum of four untreated coeliac disease patients, and three
control individuals without coeliac disease who displayed normal mucosal histology. Diagnosis was made according to established
morphological criteria using haematoxylin-eosin-stained and anti-CD3-labelled tissue sections (Dunnill and Whitehead, 1972; Marsh,
1992). Protein extracts were prepared from tissue homogenates in 1% Nonidet P-40, 1% deoxycholic acid in 25 mM Tris-HCl, 50 mM
NaCl, pH 8.0, and 150 mg of total protein from each sample was separated using 7.5% SDS-PAGE under reducing conditions.Meprin
was detected with anti-human meprin a/b cross-reactive polyclonal antibodies on Western blots using enhanced chemiluminescence
(Amersham Biosciences, Little Chalfont, UK). (A) Meprin a and b in untreated coeliac disease patients compared to normal controls.
(B) Representative example of an organ culture experiment with tissue explants from an untreated coeliac disease patient. Equally
sized tissue pieces of a biopsy were analysed immediately, or after a 24-h culture period in the presence or absence of 1 mg/ml of
a peptic tryptic digest of gliadin (Sigma Chemical Co., St. Louis, MO, USA) (Fais et al., 1992). Meprin was expressed irrespective of
gliadin treatment. Multiple bands (83–103 kDa) are detected, corresponding to differentially glycoslyated forms and to precursor and
proteolytically processed mature proteins (Sterchi et al., 1988a). Arrows indicate mature meprin a and b. The asterisk indicates an
additional form present in some biopsies.
We analysed the expression of meprin in inflamed
mucosa of untreated coeliac disease patients using
Western blotting and probing with polyclonal antibodies
generated in our laboratory and previously characterised
(Gru¨nberg et al., 1993; Lottaz et al., 1999a). The analysis
of human clinical specimens was approved by the Hack-
ney and District Health Authority (London, UK) and the
Ethics Committee of the Medical Faculty, University of
Bern (Bern, Switzerland). Variable levels of the precursor
and mature forms of meprin, exhibiting apparent molec-
ular masses between 80 and 110 kDa, were detected in
protein extracts of small intestinal biopsies of control
mucosa, as well as in active coeliac disease (Figure 1A).
Accordingly, biopsies of coeliac disease patients, which
were cultured in the presence of a peptic tryptic digest
of gliadin, retained significant meprin levels (Figure 1B).
The significant expression in coeliac disease was not
expected, as differentiated enterocytes, which constitute
the main expression site in normal mucosa (Sterchi et al.,
1988b; Lottaz et al., 1999a), are diminished in the intes-
tinal mucosa in active coeliac disease.
Organ cultures of human foetal gut have been used as
a model to demonstrate the crucial role of T-cells and
MMPs in the tissue-damaging immune response in the
gut (MacDonald and Spencer, 1988; Pender et al., 1997;
MacDonald et al., 1999; Monteleone et al., 1999, 2001b).
We therefore analysed meprin in the foetal gut system,
using well-established procedures that promote T-cell
activation and mucosal degradation. Organ cultures were
treated with either pokeweed mitogen, or a combination
of anti-CD3 antibodies and interferon-a (Figure 2). The
latter stimulus was chosen because of enhanced expres-
sion of interferon-a in coeliac disease (Monteleone et al.,
2001a). Meprin a was mostly secreted from cultured ex-
plants and accumulated in the supernatant, whereas only
small amounts of cell-associated precursor forms were
detected in tissue. The molecular species of meprin a in
foetal gut displayed the expected apparent molecular
masses of the precursor and mature forms in tissue and
supernatant, respectively, and corresponded to those
found in meprin a-transfected control cells. In contrast
to the mature mucosa of the human small intestine,
meprin b was not significantly expressed in foetal organ
cultures. In this respect, the foetal gut resembles the
colon in the adult, where meprin b is not expressed and
meprin a is secreted (Lottaz et al., 1999a). Secretion of
meprin a in the absence of meprin b has been described
previously in cell culture systems (Gru¨nberg et al., 1993;
Eldering et al., 1997; Lottaz et al., 1999a) and meprin b
knockout animals (Norman et al., 2003). The predominant
presence of meprin a protein in the human foetal gut
points to independent regulation of meprin a and b dur-
ing development and maturation of the intestine. A sim-
ilarly independent regulation of both subunits has
previously been described in postnatal development in
rats (Henning et al., 1999). Moreover, Caco-2 cells,
human colon carcinoma cells that constitutively express
meprin a but not meprin b, also display a foetal gene
expression pattern (Zweibaum et al., 1984; Lottaz et al.,
1999b).
Pokeweed mitogen did not alter the expression of
meprin a in the foetal gut, nor did it induce meprin b
(Figure 2A). Neither anti-CD3 nor interferon-a alone or
together affected secretion of meprin a (Figure 2B). Thus,
meprin was not changed upon T-cell stimulation in the
foetal gut system. The foetal gut system has limitations
as a model of mucosal inflammation, and the foetal and
adult mucosal immune system display marked differenc-
es (Spencer et al., 1986). However, injury to epithelial
cells is a common hallmark of the inflammatory response
in foetal gut, as well as in coeliac disease. As the main
expression site of meprin in healthy mucosa is the epi-
thelium (Lottaz et al., 1999a), we hypothesised that
inflammation would reduce meprin expression. This
hypothesis was disproved, as demonstrated by both the
foetal gut system and analysis of intestinal mucosa from
coeliac disease patients, which both showed sustained
expression of meprin during inflammation.
To identify the cellular source of meprin, in situ hybri-
disation was performed on tissue sections from coeliac
disease patients and normal controls. In mucosal biop-
sies of control patients, meprin a and b mRNAs were
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Figure 2 Expression of meprin a in the human foetal gut model
of T-cell-mediated mucosal inflammation.
Second-trimester human foetal small intestine (15–16 weeks of
gestation) was obtained within 2 h of surgical termination from
the Medical Research Council Tissue Bank, Hammersmith Hos-
pital (London, UK), and Homerton Hospital (London, UK). Foetal
gut organ culture in serum-free medium was performed as pre-
viously described (MacDonald and Spencer, 1988; Lionetti et al.,
1993). Tissue protein extracts (tissue) and organ culture super-
natants (sup) were analysed on Western blots. Experiments were
carried out at least three times, with representative samples
shown. (A) Human foetal gut explants were organ-cultured dur-
ing 4 days in the presence of the polyclonal T-cell activator
pokeweed mitogen (10 mg/ml, Sigma Chemical Co., Poole, UK).
As a control, protein extracts and culture supernatants (sup)
from meprin a- and meprin b-transfected Madin Darby canine
kidney (MDCK) cells are also shown (Eldering et al., 1997). Mul-
tiple forms were detected in cell lysates, corresponding to pre-
cursors and proteolytically processed forms, as previously
described (Gru¨nberg et al., 1993; Eldering et al., 1997; Pischitzis
et al., 1999). Meprin a is constitutively expressed in foetal gut
organ cultures and accumulates in culture supernatants. Mature
meprin a was secreted from tissue explants similar to meprin a-
transfected cells. Molecular forms of meprin a in the foetal gut
corresponded to meprin a-transfected cells. In the foetal gut,
tissue-associated forms were detectable only after extended
exposure of the blot, whereas mature soluble meprin a was
abundantly present in the supernatant, indicating efficient proc-
essing and secretion of the protease. Pokeweed mitogen treat-
ment did not change this pattern. Meprin b, which accumulates
at the plasma membrane in transfected cells, was hardly detect-
able in foetal gut tissue, and was not upregulated by pokeweed
mitogen. (B) Foetal gut explants were incubated with anti-CD3
monoclonal antibody (OKT3 supernatant, 5% final dilution) and
200 IU/ml IFN-a2b (National Institute of Biological Standards
and Control, Potters Bar, UK) alone, or simultaneously with both
molecules to promote synergistic T-cell activation (Monteleone
et al., 2001b). Meprin a in cell culture supernatants was ana-
lysed by Western blotting. Meprin a secretion was not visibly
affected in anti-CD3- and/or IFN-a-treated organ cultures.
Figure 3 Lamina propria leukocytes expressing meprin a and
meprin b mRNA are present at higher abundance in the small
intestinal mucosa in coeliac disease.
In situ hybridisation (ISH) of sections from formaldehyde-fixed
and paraffin-embedded tissues was performed with w35Sx-CTP-
labelled meprin a- and meprin b-specific RNA probes (Lottaz et
al., 1999a). Samples from 20 untreated coeliac disease patients
exhibiting partial or complete mucosal atrophy were analysed in
comparison with 11 samples showing normal duodenal histol-
ogy (eight treated coeliac disease patients and three healthy
controls not diagnosed with coeliac disease). Representative
examples are shown of an untreated coeliac disease patient
exhibiting mucosal atrophy and a dense infiltrate of lamina pro-
pria leukocytes (B, D) and a healthy control (A, C). (A, B) ISH for
meprin a. (C, D) ISH for meprin b. In healthy mucosa, meprin a
and meprin b mRNAs are predominantly detected in epithelial
cells in crypts and along the villus. A few lamina propria leuko-
cytes also express meprin. In coeliac disease, meprin a- and b-
positive lamina propria leukocytes are more abundant, whereas
expression in epithelial cells at the mucosal surface is low
(arrowheads). L, lumen of the gut; C, crypt. Insets: enlarged area
depicting meprin-positive (filled arrow) and -negative cells (open
arrow). Counterstain, nuclear fast red. Original objective mag-
nification, 20=. The scale bar represents 50 mm.
predominantly expressed in epithelial cells lining the villi
and crypts (Figure 3A, C). In contrast, meprin a- and b-
positive cells were abundantly present within the dense
population of macrophages and lymphocytes in the lam-
ina propria in untreated patients with active coeliac dis-
ease (Figure 3B, D). In treated patients and healthy
controls, the relative number of meprin a- and b-positive
cells in the lamina propria was below 10%. In contrast,
in untreated coeliac disease patients, up to 35% and
38% of lamina propria cells expressed meprin a and
meprin b, respectively, and all but two patients had at
least 10% meprin-positive lamina propria cells. The mor-
phology of nuclei in meprin-positive cells was in accor-
dance with lymphocytes and macrophages (Figure 3,
insets). We performed CD3 staining of serial sections of
coeliac disease tissue adjacent to the sections used for
in situ hybridisation. The pattern of CD3-positive and
meprin-positive cells differed significantly, suggesting
that only a portion of the meprin-positive cells might be
T-cells and that additional cell types contribute to meprin
expression (data not shown). We did not succeed in iso-
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lating enough lamina propria cells from single coeliac dis-
ease biopsies to characterise the meprin-expressing cell
populations in more detail using cell sorting and RT-PCR.
However, we previously detected meprin a and meprin b
in a subset of CD45-positive lamina propria leukocytes
isolated from surgical specimens of the normal human
ileum (Lottaz et al., 1999a). Meprin b was also detected
in leukocytes from mesenteric lymph nodes, as well as
in lamina propria macrophages in mice (Crisman et al.,
2004). In contrast to the lamina propria, epithelial meprin
mRNA at the mucosal surface was reduced in coeliac
disease compared to control mucosa. Therefore, the cel-
lular localisation for meprin shifts from the epithelium in
healthy mucosa to the lamina propria in coeliac disease.
This explains the lack of major changes in total expres-
sion levels on Western blots. This may not be a general
feature of mucosal inflammation in the small intestine.
Preliminary data indicate that, similarly to healthy muco-
sa, meprin was expressed predominantly in epithelial
cells in inflamed mucosa of Crohn’s disease patients
(unpublished data). The redistribution of meprin expres-
sion from the epithelium to the lamina propria completely
changes the substrate repertoire for meprin: whereas the
substrates are normally proteins present in the lumen,
meprin in coeliac disease has access to the extracellular
matrix, growth factors, chemokines and cytokines in the
lamina propria, thereby shaping the inflammatory
response.
Meprin a and meprin b display different substrate
specificities and prefer different cleavage sites. Although
both enzymes accommodate a range of different amino
acids, there are some preferences, in particular at P9
positions (Bertenshaw et al., 2001). Using a dodecamer
peptide library, meprin a was found to prefer serine at
P19 and proline at P29 and P39 positions, whereas meprin
b preferentially cleaved at sequences containing acidic
residues (aspartate and glutamate) at P19 and P29 posi-
tions, and proline at P39. Proline at P19 was not tolerated.
Although the preference for these residues is not exclu-
sive, we speculate that gluten-derived peptides, which
are the causative agents in coeliac disease and contain
sequences matching the preferences mentioned, are
substrates for meprin. Meprin b has recently been shown
to activate pro-IL-1b in vitro (Herzog et al., 2005), a cyto-
kine that is expressed in coeliac disease (Lahat et al.,
1999). Meprin also cleaves components of the basement
membrane in vitro, such as laminin 1 and 5, nidogen and
collagen IV (Kaushal et al., 1994; Walker et al., 1998;
Ko¨hler et al., 2000). The latter activity implicates meprin
in cell migration through the basement membrane, a
hypothesis that is supported by the observation that leu-
kocytes isolated from mesenteric lymph nodes of meprin
b-deficient mice displayed reduced migratory capacity
through Matrigel (Crisman et al., 2004). Transmigration
through the basement membrane is particularly impor-
tant for intraepithelial lymphocytes, which are present in
increased numbers in coeliac disease (Marsh, 1992;
Halstensen and Brandtzaeg, 1993; Jabri et al., 2000).
In summary, we observed a relocalisation of meprin
expression from the epithelial cell layer to a mixed pop-
ulation of lymphocytes in the lamina propria in coeliac
disease. In the normal small intestine, the bulk of the pro-
tease is expressed in enterocytes, targeted to the brush
border membrane and partially secreted into the gut
lumen, thereby encountering luminal substrates. In con-
trast, in situ hybridisation experiments presented here
show that gluten-induced inflammation in the small intes-
tinal mucosa of coeliac disease patients is accompanied
by the predominant expression of meprin a and b in
lamina propria leukocytes, concomitantly with reduced
expression in epithelial cells, thus leading to the accu-
mulation of meprin beneath the epithelial cell layer. Our
results highlight the importance of detailed information
on the temporal and spatial expression of a given pro-
tease in a specific biological context.
We identified meprin as a player within the protease
network in coeliac disease. The pathogenetic implica-
tions of increased meprin expression in the lamina pro-
pria remain to be elucidated, as well as the regulation of
meprin in leukocytes. However, the in vitro activity profile
of meprin suggests that it is involved in modulation of the
inflammatory response at multiple levels. It remains to be
seen whether meprin aggravates or dampens inflamma-
tion overall. For this purpose, use of meprin-deficient
mice in animal models of mucosal inflammation may
prove very helpful (Crisman et al., 2004). Ultimately,
determination of the biological function of meprin in the
intestinal mucosa depends on identification of the rele-
vant substrates in the gut lumen and within the lamina
propria.
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